Edit |   |
---|---|
Antigenic Specificity | TNFSF11/CD254 (Denosumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG2 kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Denosumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TNFSF11/CD254, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Denosumab is a novel, fully human IgG2 monoclonal antibody specific to receptor activator of nuclear factor kappa-B ligand (RANKL), suppresses bone resorption markers in patients with a variety of metastatic tumors and is being investigated in multiple clinical trials for the prevention and treatment of bone metastases. Chemically, it consists of 2 heavy and 2 light chains. Each light chain consists of 215 amino acids. Each heavy chain consists of 448 amino acids with 4 intramolecular disulfides. FDA approved on June 1, 2010. |
Immunogen | n/a |
Other Names | Denosumab, TNFSF11/CD254, 615258-40-7 |
Gene, Accession # | CAS: 615258-40-7 |
Catalog # | abx831133 |
Price | please inquire |
Order / More Info | TNFSF11/CD254 (Denosumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950